Bioanalytical Solutions for Biomarkers
Altasciences supports both preclinical and clinical studies covering many disease indications, such as oncology, metabolic disease, neurology, diabetes, inflammation, and more. Our integrated approach involves bringing in toxicologists and clinical pharmacologists to develop a comprehensive preclinical to clinical plan to maximize the translation of results from one phase to the next.
We will help guide you towards a robust and effective biomarker solution, using state-of-the-art technologies that include:
- Mass spectrometry
- Flow cytometry
- Cell-based assays
- Quantitative PCR
Discover the difference.
Questions? Speak with our scientists.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
You may also be interested in the following: